RxDoctor Payments Data

Christine Persinger, MD

Family Medicine · Springfield, OHNPI 1588928188

Payments from drug & device makers

$1,711in general payments, 2019–2025

Across 114 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$277
  • AbbVie$249
  • AstraZeneca$170
  • Astellas Pharma US Inc$164
  • Lilly USA, LLC$162
  • Novo Nordisk$125
  • plus $563 from 13 others

What the payments were for

  • Food & beverage$1,62695%
  • Education$855%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,711 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$84,258
Medicare patients
242
Services billed
1,362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide88$105,595
JardianceEmpagliflozin79$84,840
EliquisApixaban60$78,354
FarxigaDapagliflozin Propanediol38$47,590
OzempicSemaglutide41$46,862
JanuviaSitagliptin Phosphate31$37,440
MounjaroTirzepatide16$29,501
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$29,168
XareltoRivaroxaban24$21,054
JanumetSitagliptin Phos/Metformin Hcl24$18,127
Praluent PenAlirocumab23$11,389
Repatha SureclickEvolocumab18$9,662
ByettaExenatide11$8,750
Repatha SyringeEvolocumab11$7,574
Atorvastatin Calcium531$6,939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$162$135,096104 claims
Boehringer IngelheimJardiance$44$84,84079 claims
AstraZenecaFarxiga, Byetta, Symbicort$170$60,85264 claims
MerckJanuvia, Janumet$88$55,56755 claims
Novo NordiskOzempic$125$46,86241 claims
GSKTrelegy Ellipta$37$29,16829 claims
Johnson & JohnsonXarelto$15$21,05424 claims
AbbVieSynthroid$249$4,426104 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Springfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →